The industry-focused CAR-TCR Summit Europe is dedicated to developing, translating and delivering next generation CAR and TCR therapies for patients in Europe.

Join over 250 of Europe’s leading drug developers to learn about never-before-seen clinical updates and novel technology to improve solid tumour targeting, advance allogeneic therapy development and automate manufacturing processes in order to create a targeted, efficacious and commercially viable cancer therapy.

For more information, visit www.cartcr-europe.com